These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7222732)
61. In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist. Zhou L; Dockens RC; Liu-Kreyche P; Grossman SJ; Iyer RA Drug Metab Dispos; 2012 Jun; 40(6):1093-103. PubMed ID: 22381334 [TBL] [Abstract][Full Text] [Related]
62. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats. Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755 [TBL] [Abstract][Full Text] [Related]
63. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey. Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729 [TBL] [Abstract][Full Text] [Related]
64. Pharmacological characterization of teroxirone, a triepoxide antitumor agent, in rats, rabbits, and humans. Ames MM; Kovach JS; Rubin J Cancer Res; 1984 Sep; 44(9):4151-6. PubMed ID: 6744326 [TBL] [Abstract][Full Text] [Related]
66. Ciclesonide disposition and metabolism: pharmacokinetics, metabolism, and excretion in the mouse, rat, rabbit, and dog. Guo Z; Gu Z; Howell SR; Chen K; Rohatagi S; Cai L; Wu J; Stuhler J Am J Ther; 2006; 13(6):490-501. PubMed ID: 17122529 [TBL] [Abstract][Full Text] [Related]
67. Disposition and metabolism of a new steroidal anti-inflammatory agent, deflazacort, in cynomolgus monkeys. Assandri A; Ferrari P; Perazzi A; Ripamonti A; Tuan G; Zerilli L Xenobiotica; 1983 Mar; 13(3):185-96. PubMed ID: 6613164 [TBL] [Abstract][Full Text] [Related]
68. [Pharmacokinetics and metabolite pattern of clenbuterol in the rat]. Kopitar Z; Zimmer A Arzneimittelforschung; 1976; 26(7a):1435-41. PubMed ID: 1036935 [TBL] [Abstract][Full Text] [Related]
69. Absorption, distribution and excretion of 14C-pilocarpine following oral administration to rats. Omori Y; Endo T; Hara Y; Nishiyama M; Midgley I; Smart CI; John AJ; Chasseaud LF; McBurney A; John BA Arzneimittelforschung; 2004; 54(3):171-8. PubMed ID: 15112864 [TBL] [Abstract][Full Text] [Related]
70. The fate of ingested glyceran esters of condensed castor oil fatty acids [polyglycerol polyricinoleate (PGPR)] in the rat. Howes D; Wilson R; James CT Food Chem Toxicol; 1998; 36(9-10):719-38. PubMed ID: 9737418 [TBL] [Abstract][Full Text] [Related]
71. [Absorption, distribution, excretion and metabolism of [14C] T-3761 in rats and mice]. Hayakawa H; Hayashi K; Sakai H; Ishikura H; Takagi H; Nakajima Y; Sogame Y Jpn J Antibiot; 1995 May; 48(5):671-85. PubMed ID: 7637202 [TBL] [Abstract][Full Text] [Related]
72. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. Hümpel M; Illi V; Milius W; Wendt H; Kurowski M Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806 [TBL] [Abstract][Full Text] [Related]
73. Studies on the absorption, distribution and elimination of 6-o-chlorophenyl-2,4-dihydro-2(N-methyl-piperazin-1-yl)-methylene-8-nitro-1H-imidazo[1,2-a] [1,4]benzodiazepin-1-one methanesulphonate in the male rat and rabbit. James GW; Kennewell PD; Taylor JB; Luscombe DK; Nicholls PJ Eur J Drug Metab Pharmacokinet; 1979; 4(1):15-21. PubMed ID: 38121 [TBL] [Abstract][Full Text] [Related]
74. Kinetics of monochloroacetic acid at subtoxic and toxic doses in rats after single oral and dermal administrations. Saghir SA; Rozman KK Toxicol Sci; 2003 Nov; 76(1):51-64. PubMed ID: 12915718 [TBL] [Abstract][Full Text] [Related]
75. Disposition and metabolism of a novel diurea inhibitor of acyl CoA: cholesterol acyltransferase (YM17E) in the rat and dog. Uchida T; Nakamura E; Usui T; Imasaki H; Kawakami R; Watanabe T; Higuchi S Xenobiotica; 1994 Dec; 24(12):1223-36. PubMed ID: 7771109 [TBL] [Abstract][Full Text] [Related]
76. The biotransformation and disposition of bronopol following topical and intravenous administration to rats. Buttar HS; Downie RH Toxicol Lett; 1980 Jul; 6(2):101-7. PubMed ID: 7414618 [TBL] [Abstract][Full Text] [Related]
77. In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers. Hui X; Hewitt PG; Poblete N; Maibach HI; Shainhouse JZ; Wester RC Pharm Res; 1998 Oct; 15(10):1589-95. PubMed ID: 9794502 [TBL] [Abstract][Full Text] [Related]
78. Metabolic fate of the new angiotensin-converting enzyme inhibitor imidapril in animals. 1st communication: absorption, pharmacokinetics and excretion in rats and dogs. Yamada Y; Endo M; Kohno M; Otsuka M; Takaiti O Arzneimittelforschung; 1992 Apr; 42(4):457-65. PubMed ID: 1642668 [TBL] [Abstract][Full Text] [Related]
79. Pre-systemic metabolism of viprostol in the monkey following oral and topical administration. Nicolau G; Tonelli AP; Cosulich DB; Perkinson NA; DiCioccio AT; McWilliams WE; Yacobi A Xenobiotica; 1988 Jul; 18(7):797-802. PubMed ID: 3176518 [TBL] [Abstract][Full Text] [Related]
80. Comparative metabolism of radiolabeled muraglitazar in animals and humans by quantitative and qualitative metabolite profiling. Zhang D; Wang L; Raghavan N; Zhang H; Li W; Cheng PT; Yao M; Zhang L; Zhu M; Bonacorsi S; Yeola S; Mitroka J; Hariharan N; Hosagrahara V; Chandrasena G; Shyu WC; Humphreys WG Drug Metab Dispos; 2007 Jan; 35(1):150-67. PubMed ID: 17062777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]